Elsevier

Talanta

Volume 147, 15 January 2016, Pages 82-89
Talanta

A potential tool for diagnosis of male infertility: Plasma metabolomics based on GC–MS

https://doi.org/10.1016/j.talanta.2015.09.040Get rights and content

Highlights

  • Plasma profiles based on GC–MS was utilized to metabolomic analysis of male infertility.

  • Erectile dysfunction and semen abnormalities were analyzed, respectively.

  • Two variable selection methods were both applied to screen potential biomarkers.

Abstract

Male infertility has become an important public health problem worldwide. Nowadays the diagnosis of male infertility frequently depends on the results of semen quality or requires more invasive surgical intervention. Therefore, it is necessary to develop a novel approach for early diagnosis of male infertility. According to the presence or absence of normal sexual function, the male infertility is classified into two phenotypes, erectile dysfunction (ED) and semen abnormalities (SA). The aim of this study was to investigate the GC–MS plasma profiles of infertile male having erectile dysfunction (ED) and having semen abnormalities (SA) and discover the potential biomarkers. The plasma samples from healthy controls (HC) (n=61) and infertility patients with ED (n=26) or with SA (n=44) were analyzed by gas chromatography–mass spectrometry (GC–MS) for discrimination and screening potential biomarkers. The partial least squares-discriminant analysis (PLS-DA) was performed on GC–MS dataset. The results showed that HC could be discriminated from infertile cases having SA (AUC=86.96%, sensitivity=78.69%, specificity=84.09%, accuracy=80.95%) and infertile cases having ED (AUC=94.33%, sensitivity=80.33%, specificity=100%, accuracy=87.36%). Some potential biomarkers were successfully discovered by two commonly used variable selection methods, variable importance on projection (VIP) and original coefficients of PLS-DA (β). 1,5-Anhydro-sorbitol and α-hydroxyisovaleric acid were identified as the potential biomarkers for distinguishing HC from the male infertility patients. Meanwhile, lactate, glutamate and cholesterol were the found to be the important variables to distinguish between patients with erectile dysfunction from those with semen abnormalities. The plasma metabolomics may be developed as a novel approach for fast, noninvasive, and acceptable diagnosis and characterization of male infertility.

Introduction

Infertility, defined as the failure of a couple to conceive after one year of regular sexual activity without a contraceptive method, is regarded to be a major public health problem [1]. It is conservatively estimated that the male partner contributes approximately 30–55% of human infertility in reproductive-age couples [2]. Male infertility (MI) patients are classified into two phenotypes according to the presence or absence of normal sexual function [3]. The MI with normal sexual function (e.g., asthenospermia, oligozoospermia, azoospermia) and MI with sexual dysfunction (e.g., erectile dysfunction) have different pathogenesis. Erectile dysfunction (ED), a kind of sexual dysfunction, was defined as the inability to produce or maintain an erection for the sexual intercourse. It has a significant impact on quality of life of millions of men [4]. Furthermore, erectile dysfunction is less responsive to normal sperm examination. The incidence of the patients with normal sexual function (the so called semen abnormalities, SA) is usually accompanied by qualitative (e.g., asthenospermia) and quantitative (e.g., azoospermia) abnormalities of sperm [5].

In addition to a medical history questionnaire, physical examination, endocrine evaluation and so on, the most common diagnosis of male infertility involves the evaluation of basic semen analysis (sperm concentration, motility, and morphology) [6]. Moreover, some diagnostic techniques (e.g., testicular biopsy) that are invasive and may cause testicular damage are usually applied for the men who have normal or inconclusive results in routine tests to give a definite result [7]. These tests were labor intensive, time consuming and uncomfortable or unacceptable for patients. Furthermore, the molecular mechanisms underlying MI are still obscure. Specifically, 60–75% of MI patients are given descriptive diagnosis that do not provide a clear cause for their idiopathic infertility [8]. Therefore, it is necessary to find a non-invasive platform and screen robust biomarkers in clinical diagnosis and molecular mechanism study of ED and SA.

Metabolomics is a newly developed approach for systems biology. It encompasses the comprehensive and systematic profiling of metabolites and cellular and systemic changes in response to environmental influences, genetic modulations, and disease or drug perturbations [9]. Equipped with advanced high-throughput analytical technologies and bioinformatics tools, metabolomics has become an irreplaceable technology to provide for assessment of global changes in small molecular signatures [10]. These assets make metabolomics suitable for the system analysis in MI.

In metabolic profiling studies of MI, seminal fluid is usually used, but the production of a semen sample is an embarrassing, difficult, and stressful experience [11], [12], [13]. Instead, plasma or serum may be better potential biologic matrix as they are easy and convenient to acquire [14]. Recently, serum metabolic profiles from an uncontrolled population presenting different sperm concentrations were found to be significantly different, and the peptides related to the protein complement C3f were identified as putative biomarkers. The plasma metabolome can indicate global bodily functional changes [15]. Many previous studies have highlighted the intimate correlation between plasma and several diseases, including isolated post-challenge diabetes [16], metabolic syndrome [17], and sepsis-induced acute lung injury [18]. However, with regards to MI in particular, no comprehensive plasma metabolomics study based on GC–MS has been conducted to date.

Gas chromatography–mass spectrometry (GC–MS) was used as a robust analytical tool in metabolomics, due to high separation efficiency, sensitive detection and good reproducibility to resolve the complex biological mixtures [19], [20]. Besides, the identification of metabolites based on GC–MS is convenient by comparing their mass spectrum and retention index with authentic reference standards or commercial libraries [21].

A cornerstone of metabolomics study is the analysis of large amount and multi-dimensional data obtained from these technologies [17]. As a solution, many chemometrics methods were employed to project the multivariate data into lower dimensions and explore differences between groups of samples [22]. Partial least squares discriminant analysis (PLS-DA) is the most attractive method in metabolomics research among all known methods [23], [24], [25]. PLS-DA can provide good insight into the causes of discrimination via weights and loadings, which gives it a unique role in exploratory data analysis, for example in metabolomics via visualization of significant variables such as metabolites [26]. There are several PLS-DA based variable selection methods used for screening accurate and robust biomarkers, including the variable importance on projection (VIP), original coefficients of PLS-DA (β) and so on.

In this study, to characterize plasma profiles in male infertility, a metabolomics method was proposed, based on GC–MS and PLS-DA followed by two variable selection methods. The objective of this preliminary study was to comprehensively investigate whether the plasma metabolome can be used to differentiate fertile individuals from MI patients including ED and SA, subsequently to explore the potential biomarkers for the complementary prognosis of ED and SA, respectively.

Section snippets

Chemicals and reagents

BSTFA+1% TMCS (N,O-bis (trimethylsilyl) trifluoroacetamide with 1% trimethylchlorosilane, for GC) (>99.0% purity), methoxyamine hydrochloride (>98.0% purity) and pyridine (>99.8% purity), internal standard 2-isopropylmalic acid (>98.0% purity) and the other 18 chemical standards of metabolites (shown in Table 1) were commercially obtained from Sigma-Aldrich (St. Louis, MO, USA). High performance liquid chromatography (HPLC) grade methanol was purchased from the Tedia Company (Inc., Fairfield,

GC–MS profiles of plasma samples

The typical total ion chromatograms (TICs) of plasma metabolic profiling for a healthy control, a SA patient and an ED patient are shown in Fig. 1. As can be seen in Fig. 1, the plasma metabolites in all groups were similar, while the concentrations of some metabolites were different. The result illustrated that these GC–MS profiles could represent the differences among three groups.

Thirty-eight metabolites were qualitatively and quantitatively analyzed in detail, as shown in Table 1. Among the

Conclusions

In summary, this study demonstrated that using GC–MS method followed by multivariate statistical analysis, plasma profile could discriminate the controls, SA patients and ED patients. Moreover, the identified potential biomarkers could be used to distinguish SA patients from healthy controls and ED patients from healthy controls by two variable selection methods based on PLS-DA. Two metabolites, 1,5-anhydro-sorbitol and α-hydroxyisovaleric acid were selected as common biomarker candidates for

Acknowledgments

The authors gratefully thank the National Natural Science Foundation of China for support of the projects (Grant nos. 21175157 and 21375151).

References (46)

  • R.C. Rosen et al.

    The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction

    Urology

    (1997)
  • J. Jaumot et al.

    A graphical user-friendly interface for MCR-ALS: a new tool for multivariate curve resolution in MATLAB

    Chemom. Intell. Lab. Syst.

    (2005)
  • W.J. Sexton et al.

    Effect of diabetes mellitus upon male reproductive function

    Urology

    (1997)
  • A. Agarwal et al.

    Role of antioxidants in treatment of male infertility: an overview of the literature

    Reprod. Biomed. Online

    (2004)
  • M. Shamsi et al.

    DNA integrity and semen quality in men with low seminal antioxidant levels

    Mutation Res./Fundam. Mol. Mech. Mutagen.

    (2009)
  • A. Gupta et al.

    Efficacy of Withania somnifera on seminal plasma metabolites of infertile males: a proton NMR study at 800 MHz

    J. Ethnopharmacol.

    (2013)
  • S. Maqdasy et al.

    Cholesterol and male fertility: what about orphans and adopted?

    Mol. Cell. Endocrinol.

    (2013)
  • S.A. Kaplan et al.

    The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?

    J. Urol.

    (2006)
  • L.C. Callister

    Global infertility: are we caring yet?

    MCN: Am. J. Matern./Child Nurs.

    (2010)
  • G. Derosa et al.

    Glyco-metabolic profile among type 2 diabetic patients with erectile dysfunction

    Endocr. J.

    (2012)
  • F. Deepinder, H.T. Chowdary, A. Agarwal, Role of metabolomic analysis of biomarkers in the management of male...
  • O. Beckonert et al.

    Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts

    Nat. Protoc.

    (2007)
  • L. Pauling et al.

    Quantitative analysis of urine vapor and breath by gas–liquid partition chromatography

    Proc. Natl. Acad. Sci. USA

    (1971)
  • Cited by (37)

    • Fully automatic resolution of untargeted GC-MS data with deep learning assistance

      2022, Talanta
      Citation Excerpt :

      The sensitivity, specificity, and accuracy of the PLS-DA model are 0.986, 1.000, and 0.993, respectively. The performance metrics are higher than those obtained from peak area table resolved with manual intervention in the literature [36]. These results reveal that DeepResolution2 is a reliable tool for large-scale metabolomic datasets.

    • Omics applications in reproductive medicine

      2022, Biotechnology in Healthcare, Volume 1: Technologies and Innovations
    • Seminal plasma metabolomics profiles following long (4–7 days) and short (2 h) sexual abstinence periods

      2021, European Journal of Obstetrics and Gynecology and Reproductive Biology
      Citation Excerpt :

      Despite the notable developments in metabolomics technology, the relatively lower number of metabolites identified in sperm and HSP may be because the 'omics' techniques have not been applied to their full potential in this field [4,6,13]. Nonetheless, metabolomic profiling of seminal plasma has been suggested as a possible approach for a fast and non-invasive diagnosis in the evaluation of male infertility [7,15-17]. Studies assessing HSP metabolomics profiling by LC-MS/MS as a screening tool for male infertility demonstrated a correlation between HSP metabolites and sperm concentration and morphology [18].

    • Responses in the crucian carp (Carassius auratus) exposed to environmentally relevant concentration of 17α-Ethinylestradiol based on metabolomics

      2019, Ecotoxicology and Environmental Safety
      Citation Excerpt :

      It could be concluded that EE2 exposure induced blocked energy metabolism pathway and caused adverse outcomes of reproduction of crucian carp. Oxidative stress reflects an imbalance between the systemic manifestation of ROS and the ability of a biological system to detoxify the reactive intermediates or repair the resulting damage (Zhou et al., 2016). A reduction in glycolysis and TCA cycle activity was found in the zebrafish exposed to EE2 (30 ng/L), which could be due to a shift of glucose-derived glucose-6-phosphate toward the pentose phosphate pathway to synthesize nicotinamide adenine dinucleotide phosphate (NADPH) which involved in the synthesis of antioxidant enzymes (Wit et al., 2010).

    View all citing articles on Scopus
    View full text